Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:25 PM ET 8-K
Financial Results Rackspace Technology, Inc. RXT

Rackspace Technology Financial Results

Rackspace Technology reported Q3 2026 revenue of $609 million, a 9% year-over-year decrease, driven by a 17% decline in Public Cloud revenue despite 4% growth in Private Cloud. The company raised its full-year 2026 revenue outlook by $35 million at the midpoint while maintaining its profit and EBITDA guidance. Net loss for the quarter narrowed to $54 million compared to $67 million in the prior year period.

Term
Q3 2026

“This quarter we continued to execute on our business and financial plan and reaffirm our profit outlook for the full year while modestly increasing our revenue outlook.”

Gajen Kandiah, Chief Executive Officer

“As I enter my second year as CEO, we have moved from establishing our strategy to become the operator of the full enterprise AI stack and creating the framework to execute it, to now translating our go-to-market efforts and large existing capacity footprint into further commitments, rapid deployments and high margin operations.”

Gajen Kandiah, Chief Executive Officer
4:25 PM ET 8-K
Financial Results U S Physical Therapy Inc USPH

U S Physical Therapy Financial Results

U.S. Physical Therapy hosted an earnings call to discuss its financial results for the third quarter and nine months ended September 30, 2026. The company reported record volume with 27 consecutive months of record visits and successfully transitioned its Metro New York facilities into the NYU Langone hospital partnership.

Term
Q3 2026

“With respect to visits, every month this year has been a record for that month. We are up to 27 consecutive months where that has occurred, nearly 2.5 years of record volume each and every month.”

Chris Reading, Chairman and CEO
4:24 PM ET 8-K
Financial Results P3 Health Partners Inc. PIII

P3 Health Partners Financial Results

P3 Health Partners reported Q3 2026 financial results with revenue of $396 million, up 15% year-over-year, and net income of $30.8 million. The company raised its full-year 2026 Adjusted EBITDA guidance midpoint to $100 million based on strong year-to-date performance and improved network economics.

Term
Q3 2026

“This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the care our patients receive and in the consistency of our results. We carry real momentum into 2027, as evidenced by our medical cost trend, and I am excited about what lies ahead for our patients, our providers, and our partners.”

Dr. Aric Coffman, CEO of P3
4:24 PM ET 10-Q
Financial Results Repay Holdings Corp RPAY

Repay Holdings Q3 2026 Results: Net Loss of $9.34M, Loss Widens

Repay Holdings Corp reported a significant revenue increase to $153.4 million for Q3 2026, driven largely by the acquisition of KUBRA. Despite the growth, the company recorded a net loss of $10.4 million for the quarter, impacted by higher interest expenses and depreciation following the acquisition financing.

Key figure
Net loss $9.34M
4:24 PM ET Form 4
Insider Selling Primerica, Inc. PRI

Primerica CEO Glenn J. Williams Sells $442K of Stock

Glenn J. Williams, CEO, sold 1,500 shares of Primerica, Inc. at $294.94 a share, worth $442K in total on Nov 9, 2026. Shares held after the trade: 25,221 (-5.6%).

Value
$442K
Shares
1,500
Price
$294.94
Role
CEO
Holding change
-5.6%
Trade date
Nov 9, 2026
4:23 PM ET 10-Q
Financial Results Aaon, Inc. AAON

Aaon Q3 2026 Results: Net Income $69M, Up 124.0% YoY

AAON, Inc. reported significant growth for the nine months ended September 30, 2026, with net sales increasing to $1.84 billion from $1.02 billion in the prior year period. Net income more than doubled to $172.5 million, driven by strong demand for its HVAC and data center cooling solutions, while the company maintained a solid balance sheet with total assets of $1.95 billion.

Key figure
Net income $69M · +124.0% YoY
4:23 PM ET 10-Q
Financial Results Senseonics Holdings, Inc. SENS

Senseonics Holdings Q3 2026 Results: Net Loss of $32.7M, Loss Widens

Senseonics reported total revenue of $19.6 million for the third quarter of 2026, a significant increase from $8.1 million in the prior year period. However, the company experienced a widening net loss of $101.7 million for the first nine months of 2026, driven by a substantial increase in selling, general, and administrative expenses.

Key figure
Net loss $32.7M
4:23 PM ET 10-Q
Financial Results Investors Title Co ITIC

Investors Title Q3 2026 Results: Net Income $9.43M, Down 22.8% YoY

Investors Title Company reported net income of $30.1 million for the nine months ended September 30, 2026, an increase from $27.7 million in the prior year period. Total revenues grew to $232.4 million, driven by higher net premiums written, although net income for the third quarter specifically decreased due to higher operating expenses and a significant increase in the provision for claims.

Key figure
Net income $9.43M · -22.8% YoY
4:23 PM ET 10-Q
Financial Results FutureFuel Corp. FF

FutureFuel Q3 2026 Results: Net Loss of $8.39M, Loss Narrows

FutureFuel Corp. reported a significant revenue increase to $104.7 million for the third quarter of 2026, though it still incurred a net loss of $8.4 million. The company retrospectively adjusted its financial statements following a change in inventory accounting from LIFO to weighted average cost, and results were impacted by non-recurring costs from a winter storm and a tank farm fire.

Key figure
Net loss $8.39M
4:23 PM ET 10-Q
Financial Results Galaxy Digital Inc. GLXY

Galaxy Digital Q3 2026 Results: Net Income $323M, Down 36.1% YoY

Galaxy Digital reported net income of $322.8 million for the quarter ended September 30, 2026, a decrease from $505.1 million in the prior year period. Total assets grew significantly to $16.4 billion from $11.3 billion at year-end 2025, driven by increases in investments and property and equipment, while the company introduced new data center leasing revenue.

Key figure
Net income $323M · -36.1% YoY
4:23 PM ET Form 4
Insider Selling Greene County Bancorp Inc GCBC

Greene Bancorp Insider Michelle M. Plummer Sells $355K of Stock

Michelle M. Plummer sold 10,000 shares of Greene Bancorp, Inc. at $35.52 a share, worth $355K in total on Nov 9, 2026. Shares held after the trade: 89,560 (-10.0%).

Value
$355K
Shares
10,000
Price
$35.52
Holding change
-10.0%
Trade date
Nov 9, 2026
4:23 PM ET 8-K
Capital Raise Vistra Corp. VST

Vistra Capital Raise

Vistra Corp. filed a prospectus supplement to its automatic shelf registration statement on Form S-3 for the issuance and sale of securities. This filing includes the legal opinion from Latham & Watkins LLP regarding the legality of the securities being offered.

4:23 PM ET 8-K
Financial Results AbCellera Biologics Inc. ABCL

AbCellera Biologics Financial Results

AbCellera reported Q3 2026 financial results with revenue of $10.6 million and a net loss of $40.8 million. The company highlighted positive Phase 2 data for its ABCL635 program and a $200 million capital raise that increased total liquidity to approximately $890 million.

Term
Q3 2026

“This was a transformative quarter for AbCellera, highlighted by strong clinical execution and balance sheet expansion. Positive top-line Phase 2 results for ABCL635 demonstrated an efficacy and tolerability profile that has potential to redefine the treatment of hot flashes.”

Carl Hansen, Ph.D., founder and CEO of AbCellera

“On the strength of this data, we raised $200 million, bringing our available liquidity to approximately $900 million. Together with the top-line Phase 1 readout of ABCL575 and the addition of three new pipeline programs, ABCL992, ABCL385, and ABCL646, we have delivered on all corporate priorities for 2026.”

Carl Hansen, Ph.D., founder and CEO of AbCellera
4:22 PM ET 8-K/A
M&A Deal Tidewater Inc TDW

Tidewater M&A Deal with Wilson, Sons Ultratug Participações S.A.

Tidewater Inc. filed an amendment to its previous 8-K to provide required audited financial statements and pro forma financial information following its completed acquisition of Wilson, Sons Ultratug Participações S.A. (now Tidewater Offshore do Brasil S.A.) and Atlantic Offshore Services S.A. The acquisition was originally completed on August 31, 2026.

Counterparty
Wilson, Sons Ultratug Participações S.A.
4:22 PM ET 8-K
Loan & Debt Humana Inc HUM

Humana $1.5B Debt Financing

Humana Inc. has commenced cash tender offers to purchase up to $1.5 billion in aggregate purchase price of eight different series of its outstanding senior notes. The offers include various notes with maturities ranging from 2027 to 2032, subject to acceptance priority levels and a specific $800 million series cap for the 5.375% Senior Notes due 2031. This debt management transaction allows the company to retire existing higher-interest or near-term debt using available liquidity.

Value
$1.5B
4:22 PM ET 8-K
Deal Termination Hornbeck Offshore Services, Inc. HOS

Hornbeck Offshore Services Deal Termination

Todd Hornbeck, President and CEO of Hornbeck Offshore Services, has terminated a Rule 10b5-1 trading plan originally established on September 1, 2026. The plan was intended for the sale of 1,170,405 shares of common stock, but no shares were sold prior to its cancellation.

4:22 PM ET Form 4
Insider Selling Iron Mountain Inc IRM

Iron Mountain President and CEO William L. Meaney Sells $4.07M of Stock

William L. Meaney, President and CEO, sold 38,474 shares of Iron Mountain Inc at $104.08 to $106.62 a share (average $105.72) in 4 transactions, worth $4.07M in total on Nov 6, 2026. Shares held after the trade: 0 (-100.0%).

Value
$4.07M
Shares
38,474
Average price
$105.72
Role
President and CEO
Holding change
-100.0%
Trade date
Nov 6, 2026
4:22 PM ET 10-Q
Financial Results Amneal Pharmaceuticals, Inc. AMRX

Amneal Pharmaceuticals Q3 2026 Results: Net Loss of $21.7M

Amneal Pharmaceuticals reported net revenue of $862.7 million for the third quarter of 2026, an increase from $784.5 million in the prior year period. Despite higher operating income, the company recorded a net loss attributable to Class A common stockholders of $21.7 million for the quarter, primarily due to accretion of redeemable non-controlling interests and acquisition-related costs.

Key figure
Net loss $21.7M
4:22 PM ET 10-Q
Financial Results Lineage, Inc. LINE ▶ Call

Lineage Q3 2026 Results: Net Loss of $154M, Loss Widens

For the nine months ended September 30, 2026, Lineage, Inc. reported flat net revenues of $4,019 million and a net loss of $256 million, compared to a $119 million loss in the prior year. The company's financial position shows total assets of $18,976 million and a significant increase in long-term debt to $6,813 million.

Key figure
Net loss $154M
4:22 PM ET Form 4
Insider Selling Nicolet Bankshares Inc NIC

Nicolet Bankshares EVP - Retail & Ag Banking Eric James Witczak Sells $104K of Stock

Eric James Witczak, EVP - Retail & Ag Banking, sold 600 shares of Nicolet Bankshares Inc at $173.11 a share, worth $104K in total on Nov 6, 2026. Shares held after the trade: 32,724 (-1.8%).

Value
$104K
Shares
600
Price
$173.11
Role
EVP - Retail & Ag Banking
Holding change
-1.8%
Trade date
Nov 6, 2026
4:22 PM ET 8-K
Financial Results FutureFuel Corp. FF

FutureFuel Financial Results

FutureFuel Corp. reported Q3 2026 total revenues of $104.7 million, a significant increase from the prior year, though it recorded a GAAP net loss of $8.4 million. Results were impacted by extended maintenance turnarounds in the chemicals segment and derivative losses in biofuels, despite robust biodiesel demand and multi-year high production volumes.

Term
Q3 2026

“Third quarter results reflected strong biodiesel demand and improved production economics, offset by extended maintenance on two dedicated chemicals production units that weighed on volumes, operating leverage and profitability in the period.”

Roeland Polet, Chairman and Chief Executive Officer

“Through early November, we have booked orders for more than 90% of our fourth quarter biodiesel production capacity, well ahead of prior expectations.”

Roeland Polet, Chairman and Chief Executive Officer
4:21 PM ET 10-Q
Financial Results ArriVent BioPharma, Inc. AVBP

ArriVent BioPharma Q3 2026 Results: Net Loss of $40.3M, Loss Widens

ArriVent BioPharma reported collaboration revenue of $5.0 million for the nine months ended September 30, 2026, compared to zero in the prior year. Despite this, the company saw a net loss of $133.5 million driven by $118.9 million in research and development expenses. Cash and short-term investments increased to $393.2 million, bolstered by $199.6 million in net proceeds from common stock issuances.

Key figure
Net loss $40.3M
4:21 PM ET Form 4
Insider Selling Lincoln National Corp LNC

Lincoln National EVP, Ch Ppl Comms Ent Srvc Off Sean Woodroffe Sells $704K of Stock

Sean Woodroffe, EVP, Ch Ppl Comms Ent Srvc Off, sold 17,500 shares of Lincoln National Corp at $40.24 a share, worth $704K in total on Nov 6, 2026. Shares held after the trade: 103,296 (-14.5%).

Value
$704K
Shares
17,500
Price
$40.24
Role
EVP, Ch Ppl Comms Ent Srvc Off
Holding change
-14.5%
Trade date
Nov 6, 2026
4:21 PM ET 10-Q
Financial Results Quantum Corp QMCO

Quantum Q2 2026 Results: Net Loss of $44.9M, Loss Narrows

Quantum Corp reported a significant increase in total revenue to $89.6 million for the quarter ended September 30, 2026, compared to $62.7 million in the prior year. Despite improved gross profits, the company realized a net loss of $44.9 million for the quarter, primarily driven by a $51.6 million non-cash charge related to the change in fair value of warrant liabilities.

Key figure
Net loss $44.9M
4:21 PM ET 10-Q
Financial Results World Acceptance Corp WRLD

World Acceptance Q2 2026 Results: Turns Profitable, Net Income $8.75M

World Acceptance Corporation reported net income of $8.8 million for the quarter ended September 30, 2026, a significant improvement from a $1.7 million net loss in the prior year period. The company saw a decrease in the provision for credit losses and interest expense, while total revenues grew to $139.2 million.

Key figure
Net income $8.75M
4:21 PM ET 10-K
Financial Results Amcon Distributing Co DIT

Amcon Distributing FY 2026 Results: Net Income $2.36M, Up 315.2% YoY

AMCON Distributing Co. reports that cigarette distribution accounted for 64% of consolidated revenues and 17% of gross profit in fiscal 2026. The company faces significant risks from declining cigarette demand, increasing excise taxes, and intense competition from national wholesalers and online retailers utilizing AI and direct-to-business models.

Key figure
Net income $2.36M · +315.2% YoY
4:21 PM ET Form 4
Insider Selling Grid Dynamics Holdings, Inc. GDYN

Grid Dynamics Holdings CFO Anil Doradla Sells $19.9K of Stock

Anil Doradla, CFO, sold 1,500 shares of Grid Dynamics Holdings, Inc. at $13.26 a share, worth $19.9K in total on Nov 6, 2026. Shares held after the trade: 373,009 (-0.4%).

Value
$19.9K
Shares
1,500
Price
$13.26
Role
CFO
Holding change
-0.4%
Trade date
Nov 6, 2026
4:21 PM ET 8-K
Financial Results Coherus Oncology, Inc. CHRS

Coherus Oncology Financial Results

Coherus Oncology reported Q3 2026 financial results, highlighted by $14.0 million in LOQTORZI net revenue. The company also announced a strategic prioritization plan focusing on tagmokitug for esophageal cancer and a 30% headcount reduction to lower quarterly cash burn.

Term
Q3 2026

“The strategic prioritization of esophageal cancer as our best-in-disease focus for tagmokitug, together with the Transition Services Agreement wind-down and the toripalimab process transfer completion, provides an ideal opportunity to right-size the organization and deliver financial benefits that flow directly from this prioritization”

Dennis M. Lanfear, Chief Executive Officer

“The financial benefits of right-sizing the organization and reducing the scope of our forward-focused efforts provide substantial and durable benefits to our operating model”

Bryan McMichael, Chief Financial Officer
4:21 PM ET 10-Q
Financial Results Aimco OP L.P. AIV

Aimco OP Q3 2026 Results

Aimco Operating Partnership transitioned to a liquidation basis of accounting on February 1, 2026, following the adoption of a Plan of Sale and Liquidation. As of September 30, 2026, the entity reported net assets in liquidation of $395.0 million, reflecting significant liquidating distributions to stockholders and noncontrolling interests during the period.

4:21 PM ET 10-Q
Financial Results Apartment Investment & Management Co AIV

Apartment Investment & Management Q3 2026 Results

Aimco adopted a Plan of Sale and Liquidation in early 2026, transitioning its financial reporting from a going concern basis to a liquidation basis. As of September 30, 2026, the company reported net assets in liquidation of $395.0 million, having distributed $393.5 million to stockholders during the period.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.